ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2016

Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study.

Markus F Scheerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.